감염증 진단 시장 : 기술별, 질환별(설사성 질환, 호흡기 감염증, 혈액 감염증), 최종사용자별, 지역별

Infectious Disease Diagnostics Market is estimated to be valued at USD 1,750.8 Mn in 2025 and is expected to reach USD 3,370.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.81% from 2025 to 2032.

Infectious diseases are caused by organisms such as bacteria, virus, fungi, and parasites and are capable of transmission from one species to another species. Infectious diseases spread from person to person either through direct contact or indirectly through insect bites or other vectors like food, soil, water, and air. Diagnosis of these diseases involves identifying the pathogen and its type and then diagnose infection has spread. Diagnosis is the initial step of discovering a disease and its treatment leads to elimination of infectious diseases. Infectious diseases are among the leading causes of morbidity and death. Diagnostics plays important part in deciding the course of any clinical treatment. While Infectious diseases diagnostics help in diagnosing disease caused because of pathogenic disease Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases. Traditional infectious disease diagnosis was time-consuming. Because of this factor, the Infectious Disease Diagnostics Market has seen the emergence of rapid, accurate, and portable point-of-care testing products. Point of care testing helps for faster diagnosis of infectious diseases nearby to the patient's location and provides immediate results. Several researchers are now working on multiplex point-of-care diagnostic technologies. Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular techniques, immunodiagnostics, conventional culturing, and staining techniques. Biochemical techniques include Enzyme-linked Immunosorbent Assay (ELISA), agglutination, and others, while molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Market Dynamics

Increasing prevalence of Infectious Disease Diagnostics Market is expected to drive the market growth over the forecast period, due to growing awareness for the early disease diagnostics. For instance, In 1995, According to the Centers for Disease Control and Prevention {CDCP}, Hospital-acquired infections( HAIs) in American hospitals are responsible for 1.7 million infections and 99,000 deaths occur per year. Out of all, the urinary tract infections occurs up to 32% of all the healthcare-acquired infections, followed by surgical site infections [22%], pneumonia [15%], and bloodstream infections [14%].

Key features of the study

• This report provides in-depth analysis of the global infectious disease diagnostics market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global infectious disease diagnostics market based on the following parameters -company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
• Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• Global infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

• Technology Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • ELISA
  • Polymerase Chain Reaction
  • Immunoassays
  • Cell Cultures
  • Others
• Disease Indication Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • Central nervous system (CNS) Infection
  • Meningitis
  • Brain Abscess
  • Diarrheal Disease
  • Shigellosis
  • Cholera
  • Enteric/Typhoid Fever
  • Respiratory Infections
  • Tuberculosis
  • Influenza
  • Bronchitis
  • Blood Infections
  • Malaria
  • Dengue
  • Infectious Mononucleosis
  • Others
  • STDs
  • Chlamydia
  • AIDS
  • Syphilis
  • Others
• End User Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • Hospitals
  • Diagnostics centers
  • Dermatology Clinics
  • Others (Research Institutes, Specialty Centres, etc.)
• Regional Insights (Revenue, USD Mn & KT, 2025 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players Insights
  • Becton Dickinson & Company
  • Cepheid, Inc
  • Abbott Laboratories
  • BioMerieux SA
  • Hologic, Inc
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc
  • Roche Diagnostics
  • DiaSorin S.p.A
  • Quidel Corporation
  • Bio-Rad Laboratories

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Disease Indication
  • Market Snapshot, By End Users
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Attractiveness Analysis
  • Market Opportunities
  • Product Launches
  • Merger, Acquisition, Collaborations
• Regulatory Guideline and Compliances
• Key Developments
• PEST Analysis

4. Global Infectious Disease Diagnostics Market, By Technology, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• ELISA
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
  • Segment Trends
• Polymerase Chain Reaction (PCR)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends
• Immunoassays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends
• Cell Cultures
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Segment Trends

5. Global Infectious Disease Diagnostics Market , By Disease Indication 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Central Nervous System Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Meningitis
• Brain Abscess
• Diarrheal Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Shigellosis
• Cholera
• Enteric/Typhoid Fever
• Respiratory Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Tuberculosis
• Influenza
• Bronchitis
• Blood Infections
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Malaria
• Dengue
• Infectious Mononucleosis
• Others
• Sexually transmitted diseases (STDs),
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
• Chlamydia
• AIDS
• Syphilis
• Others

6. Global Infectious Disease Diagnostics Market , By End Users 2020 - 2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segments Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Dermatology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others (Research Institutes, Specialty Centers, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Infectious Disease Diagnostics Market , By Region, 2020-2032, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication , 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Becton Dickinson & Company
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Cepheid, Inc.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Abbott Laboratries
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• BioMerieux
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Hologic, Inc.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Danaher Corportion
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Quidel Corporation
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories, Inc
  • Company Overview
  • Product Portfolio
  • Key Development
  • Financial Performance
  • Strategies

9. Section

• Research Methodology
• About Us